Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Bassaganya Riera, Josep ^a   Guri, Amir J ^a   Hontecillas, Raquel ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954593739     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/897894     Document Type: Review

References (59)

1. Malnick S. D. H., Knobler H., The medical complications of obesity. QJM 2006 99 9 565 579 2-s2.0-33749616411 10.1093/qjmed/hcl085 (Pubitemid 44540533)
2. Finkelstein E. A., Trogdon J. G., Cohen J. W., Dietz W., Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Affairs 2009 28 5 w822 w831 2-s2.0-70349207410 10.1377/hlthaff.28.5.w822
3. The United Health Federation, The American Public Health Association, partnership for prevention, The future costs of obesity: national and state estimates of the impact of obesity on direct heaalth care expenses. 2009, http://www.americashealthrankings.org/2009/spotlight.Aspx
4. Mokdad A. H., Bowman B. A., Ford E. S., Vinicor F., Marks J. S., Koplan J. P., The continuing epidemics of obesity and diabetes in the United States. Journal of the American Medical Association 2001 286 10 1195 1200 2-s2.0-0035850402 (Pubitemid 33015548)
5. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 1999 20 5 649 688 2-s2.0-0033305213 (Pubitemid 30650602)
6. Nesto R. W., Bell D., Bonow R. O., Fonseca V., Grundy S. M., Horton E. S., Le Winter M., Porte D., Semenkovich C. F., Smith S., Young L. H., Kahn R., Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the american heart association and american diabetes association. Circulation 2003 108 23 2941 2948 2-s2.0-0344304678 10.1161/01.CIR.0000103683.99399.7E (Pubitemid 37517824)
7. Katayama K., Wada K., Nakajima A., Mizuguchi H., Hayakawa T., Nakagawa S., Kadowaki T., Nagai R., Kamisaki Y., Blumberg R. S., Mayumi T., A novel PPAR γ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003 124 5 1315 1324 2-s2.0-0038185266 10.1016/S0016-5085(03)00262-2 (Pubitemid 36531806)
8. Dubuquoy L., Jansson E. A., Deeb S., Rakotobe S., Karoui M., Colombel J. F., Auwerx J., Pettersson S., Desreumaux P., Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 2003 124 5 1265 1276 2-s2.0-0037847511 10.1016/S0016-5085(03)00271-3 (Pubitemid 36531802)
9. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor super-family: the second decade. Cell 1995 83 6 835 839 2-s2.0-0012473279
10. Bassaganya-Riera J., Guri A., King J., Hontecillas R., Peroxisome proliferator-activated receptors: the nutritionally controlled molecular networks that integrate inflammation, immunity and metabolism. Current Nutrition < Food Science 2005 1 179 187
11. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). Journal of Biological Chemistry 1995 270 22 12953 12956 2-s2.0-0029016829 10.1074/jbc.270.22.12953
12. Bassaganya-Riera J., jbassaga@vt.edu Reynolds K., Martino-Catt S., Cui Y., Hennighausen L., Gonzalez F., Rohrer J., Benninghoff A. U., Hontecillas R., Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004 127 3 777 791 10.1053/j.gastro.2004.06.049 (Pubitemid 39208411)
13. Lewis J. D., Capra A. M., Achacoso N. S., Ferrara A., Levin T. R., Quesenberry C. P., Habel L. A., Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology 2008 135 6 1914 1923.e1 2-s2.0-57249086247 10.1053/j.gastro. 2008.09.004
14. Evans N. P., Misyak S. A., Schmelz E. M., Guri A. J., Hontecillas R., Bassaganya-Riera J., jbassaga@vt.edu Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPAR γ Journal of Nutrition 2010 140 3 515 521 10.3945/jn.109.115642
15. Ogino S., Shima K., Baba Y., Nosho K., Irahara N., Kure S., Chen LI., Toyoda S., Kirkner G. J., Wang Y. L., Giovannucci E. L., Fuchs C. S., Colorectal cancer expression of peroxisome proliferator-activated receptor γ (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009 136 4 1242 1250 2-s2.0-62949100452 10.1053/j.gastro.2008.12.048
16. Aldridge J. R., Moseley C. E., Boltz D. A., Negovetich N. J., Reynolds C., Franks J., Brown S. A., Doherty P. C., Webster R. G., Thomas P. G., TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America 2009 106 13 5306 5311 2-s2.0-65249145291 10.1073/pnas. 0900655106
17. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet 2010 376 9739 419 430 2-s2.0-77953887604 10.1016/S0140-6736(10)60576-4
18. Davidson M. H., Armani A., McKenney J. M., Jacobson T. A., Safety considerations with fibrate therapy. American Journal of Cardiology 2007 99 6 S3 S18 2-s2.0-33947110940 10.1016/j.amjcard.2006.11.016 (Pubitemid 46412226)
19. Guri A. J., Hontecillas R., Bassaganya-Riera J., Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clinical Nutrition 2010 29 6 824 831 2-s2.0-77949323640 10.1016/j.clnu.2010.02.009
20. Guri A. J., Hontecillas R., Bassaganya-Riera J., Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis. Clinical Nutrition 2010 29 5 646 653 2-s2.0-77649219310 10.1016/j.clnu.2010.02.003
21. Guri A. J., Hontecillas R., Ferrer G., Casagran O., Wankhade U., Noble A. M., Eizirik D. L., Ortis F., Cnop M., Liu D., Si H., Bassaganya-Riera J., Loss of PPAR γ in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue. Journal of Nutritional Biochemistry 2008 19 4 216 228 2-s2.0-39749200215 10.1016/j.jnutbio.2007.02.010 (Pubitemid 351312272)
22. Guri A. J., Hontecillas R., Si H., Liu D., Bassaganya-Riera J., Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clinical Nutrition 2007 26 1 107 116 2-s2.0-33846566783 10.1016/j.clnu.2006.07.008 (Pubitemid 46179115)
23. + T cell recruitment into the aortic wall. Journal of Nutritional Biochemistry 2010 21 12 1178 1185 2-s2.0-74249117640 10.1016/j.jnutbio.2009.10.003
24. Bassaganya-Riera J., Skoneczka J., Kingston D. G. J., Krishnan A., Misyak S. A., Guri A. J., Pereira A., Carter A. B., Minorsky P., Tumarkin R., Hontecillas R., Mechanisms of action and medicinal applications of abscisic acid. Current Medicinal Chemistry 2010 17 5 467 478 2-s2.0-77950634814 10.2174/092986710790226110
25. Hontecillas R., O'Shea M., Einerhand A., Diguardo M., Bassaganya-Riera J., Activation of PPAR γ and α by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. Journal of the American College of Nutrition 2009 28 2 184 195 2-s2.0-74049113823
26. Hontecillas R., Diguardo M., Duran E., Orpi M., Bassaganya-Riera J., Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR α expression in adipose tissue. Clinical Nutrition 2008 27 5 764 772 2-s2.0-53549116730 10.1016/j.clnu.2008.07.007
27. Lewis SN, Bassaganya-Riera J, Bevan DR., Virtual screening as a technique for ppar modulator discovery. PPAR Research 2010 2010 10 861238 10.1155/2010/861238
28. Alberts B., The breakthroughs of 2009. Science 2009 326 5960 1589 2-s2.0-74949094279
29. Cutler S. R., Rodriguez P. L., Finkelstein R. R., Abrams S. R., Abscisic acid: emergence of a core signaling network. Annual Review of Plant Biology 2010 61 651 679 2-s2.0-77952511548 10.1146/annurev-arplant-042809-112122
30. Bruzzone S., Moreschi I., Usai C., Guida L., Damonte G., Salis A., Scarfi S., Millo E., De Flora A., Zocchi E., Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADP-ribose as second messenger. Proceedings of the National Academy of Sciences of the United States of America 2007 104 14 5759 5764 2-s2.0-34347266203 10.1073/pnas.0609379104 (Pubitemid 47175607)
31. Sturla L., Fresia C., Guida L., Bruzzone S., Scarfi S., Usai C., Fruscione F., Magnone M., Millo E., Basile G., Grozio A., Jacchetti E., Allegretti M., De Flora A., Zocchi E., LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. Journal of Biological Chemistry 2009 284 41 28045 28057 2-s2.0-70350504374 10.1074/jbc.M109.035329
32. Guri A. J., Hontecillas R., Bassaganya-Riera J., Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clinical Nutrition 2006 25 6 871 885 2-s2.0-33751006412 10.1016/j.clnu.2006.08.006 (Pubitemid 44743162)
33. Odegaard J. I., Ricardo-Gonzalez R. R., Goforth M. H., Morel C. R., Subramanian V., Mukundan L., Eagle A. R., Vats D., Brombacher F., Ferrante A. W., Chawla A., Macrophage-specific PPAR γ controls alternative activation and improves insulin resistance. Nature 2007 447 7148 1116 1120 2-s2.0-34347354309 10.1038/nature05894 (Pubitemid 47014427)
34. Norris A. W., Hirshman M. F., Yao J., Jessen N., Musi N., Chen L., Sivitz W. I., Goodyear L. J., Kahn C. R., Endogenous peroxisome proliferator-activated receptor- γ augments fatty acid uptake in oxidative muscle. Endocrinology 2008 149 11 5374 5383 2-s2.0-54349092356 10.1210/en.2008-0100
35. Tanaka T., Masuzaki H., Ebihara K., Ogawa Y., Yasue S., Yukioka H., Chusho H., Miyanaga F., Miyazawa T., Fujimoto M., Kusakabe T., Kobayashi N., Hayashi T., Hosoda K., Nakao K., Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. Metabolism 2005 54 11 1490 1498 2-s2.0-27344454809 10.1016/j.metabol.2005.05.015 (Pubitemid 41527019)
36. Evans-Molina C., Robbins R. D., Kono T., Tersey S. A., Vestermark G. L., Nunemaker C. S., Garmey J. C., Deering T. G., Keller S. R., Maier B., Mirmira R. G., Peroxisome proliferator-activated receptor γ activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Molecular and Cellular Biology 2009 29 8 2053 2067 2-s2.0-64649092274 10.1128/MCB.01179-08
37. Chaggar P. S., Shaw S. M., Williams S. G., Review article: thiazolidinediones and heart failure. Diabetes & Vascular Disease Research 2009 6 3 146 152
38. Weisberg S. P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R. L., Ferrante A. W., CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006 116 1 115 124 2-s2.0-31044456529 10.1172/JCI24335 (Pubitemid 43121796)
39. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. Journal of Biological Chemistry 2006 281 36 26602 26614 2-s2.0-33748750917 10.1074/jbc.M601284200 (Pubitemid 44401869)
40. Bruzzone S., Bodrato N., Usai C., Guida L., Moreschi I., Nano R., Antonioli B., Fruscione F., Magnone M., Scarfì S., De Flora A., Zocchi E., Abscisic acid is an endogenous stimulator of insulin release from human pancreatic islets with cyclic ADP ribose as second messenger. Journal of Biological Chemistry 2008 283 47 32188 32197 2-s2.0-57749107690 10.1074/jbc.M802603200
41. Lazennec G., Canaple L., Saugy D., Wahli W., Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Molecular Endocrinology 2000 14 12 1962 1975 2-s2.0-0034530972 10.1210/me.14.12.1962 (Pubitemid 32055530)
42. Bassaganya-Riera J., Guri A. J., Lu P., Abscisic acid regulates inflammation via ligand-binding domain-independent activation of ppar gamma. Journal of Biological Chemistry. In press
43. Lu P., Bevan D. R., Lewis S. N., Hontecillas R., Bassaganya-Riera J., Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics. Journal of Molecular Modeling. In press 2-s2.0-77952686105 10.1007/s00894-010-0748-y
44. Magnone M., Bruzzone S., Guida L., Damonte G., Millo E., Scarfì S., Usai C., Sturla L., Palombo D., De Flora A., Zocchi E., Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis. Journal of Biological Chemistry 2009 284 26 17808 17818 2-s2.0-67650549689 10.1074/jbc.M809546200
45. Bodrato N., Franco L., Fresia C., Guida L., Usai C., Salis A., Moreschi I., Ferraris C., Verderio C., Basile G., Bruzzone S., Scarfi S., De Flora A., Zocchi E., Abscisic acid activates the murine microglial cell line N9 through the second messenger cyclic ADP-ribose. Journal of Biological Chemistry 2009 284 22 14777 14787 2-s2.0-67649361928 10.1074/jbc.M802604200
46. Guri A. J., Hontecillas R., Bassaganya-Riera J., Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clinical Nutrition 2010 29 6 824 831 2-s2.0-77949323640 10.1016/j.clnu.2010.02.009
47. Joh Y. G., Kim S. J., Christie W. W., The structure of the triacylglycerols, containing punicic acid, in the seed oil of Trichosanthes kirilowii. Journal of the American Oil Chemists' Society 1995 72 9 1037 1042 2-s2.0-51249165869 10.1007/BF02660718
48. Bassaganya-Riera J., Hontecillas R., Beitz D. C., Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clinical Nutrition 2002 21 6 451 459 2-s2.0-0036905233 10.1054/clnu.2002.0594 (Pubitemid 35452508)
49. O'Shea M., Bassaganya-Riera J., Mohede I. C., Immunomodulatory properties of conjugated linoleic acid. The American journal of clinical nutrition 2004 79 6 1199S 1206S 2-s2.0-2942657398
50. Kennedy A., Martinez K., Schmidt S., Mandrup S., LaPoint K., McIntosh M., Antiobesity mechanisms of action of conjugated linoleic acid. Journal of Nutritional Biochemistry 2010 21 3 171 179 2-s2.0-76749093608 10.1016/j.jnutbio.2009.08.003
51. Sassano G., Sanderson P., Franx J., Groot P., Van Straalen J., Bassaganya-Riera J., Analysis of pomegranate seed oil for the presence of jacaric acid. Journal of the Science of Food and Agriculture 2009 89 6 1046 1052 2-s2.0-63849304418 10.1002/jsfa.3552
52. Ahlers N. H. E., Dennison A. C., O'Neill L. A., Spectroscopic examination of punicic acid. Nature 1954 173 4413 1045 1046 2-s2.0-0343383849 10.1038/1731045a0
53. Kaufman M., Wiesman Z., Pomegranate oil analysis with emphasis on MALDI-TOF/MS triacylglycerol fingerprinting. Journal of Agricultural and Food Chemistry 2007 55 25 10405 10413 2-s2.0-38049077423 10.1021/jf072741q
54. Meerts I. A. T. M., Verspeek-Rip C. M., Buskens C. A. F., Keizer H. G., Bassaganya-Riera J., Jouni Z. E., van Huygevoort A. H. B. M., van Otterdijk F. M., van de Waart E. J., Toxicological evaluation of pomegranate seed oil. Food and Chemical Toxicology 2009 47 6 1085 1092 2-s2.0-67349102597 10.1016/j.fct.2009.01.031
55. Muñoz-Mingarro D., Acero N., Llinares F., Pozuelo J. M., Galán De Mera A., Vicenten J. A., Morales L., Alguacil L. F., Pérez C., Biological activity of extracts from Catalpa bignonioides Walt. (Bignoniaceae). Journal of Ethnopharmacology 2003 87 2-3 163 167 2-s2.0-0038014030 10.1016/S0378-8741(03)00111-9 (Pubitemid 36809145)
56. Remick J., Weintraub H., Setton R., Offenbacher J., Fisher E., Schwartzbard A., Fibrate therapy: an update. Cardiology in Review 2008 16 3 129 141 2-s2.0-42249113454 10.1097/CRD.0b013e31816b43d3 (Pubitemid 351549675)
57. Chawla A., Boisvert W. A., Lee C. H., Laffitte B. A., Barak Y., Joseph S. B., Liao D., Nagy L., Edwards P. A., Curtiss L. K., Evans R. M., Tontonoz P., A PPAR γ -LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 2001 7 1 161 171 2-s2.0-17744376173 10.1016/S1097-2765(01)00164-2 (Pubitemid 32162909)
58. Walczak R., Tontonoz P., PPARadigms and PPARadoxes: expanding roles for PPAR γ in the control of lipid metabolism. Journal of Lipid Research 2002 43 2 177 186 2-s2.0-0036189407 (Pubitemid 34184004)
59. Chinetti G., Lestavel S., Bocher V., Remaley A. T., Neve B., Torra I. P., Teissier E., Minnich A., Jaye M., Duverger N., Brewer H. B., Fruchart J. C., Clavey V., Staels B., PPAR- α and PPAR- γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Medicine 2001 7 1 53 58 2-s2.0-0035138625 10.1038/83348 (Pubitemid 32095642)